PBLA (Panbela Therapeutics) Median PS Value: $0.00 (As of Jul. 01, 2026)

What is Panbela Therapeutics Median PS Value?

Panbela Therapeutics PBLA +2,400.00% Median PS Value is $0.00 as of Jul. 01, 2026.

This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Panbela Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0. Panbela Therapeutics's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is $0.00.

As of today (2026-07-01), Panbela Therapeutics's share price is $0.005. Panbela Therapeutics's Median PS Value is $0.00. Therefore, Panbela Therapeutics's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Panbela Therapeutics's Median PS Value or its related term are showing as below:

PBLA's Price-to-Median-PS-Value is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.63
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Panbela Therapeutics (OTCPK:PBLA) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Panbela Therapeutics's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	0.005	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panbela Therapeutics Median PS Value Related Terms

Panbela Therapeutics Median PS Value Historical Data

* Premium members only.

The historical data trend for Panbela Therapeutics's Median PS Value can be seen below:

Panbela Therapeutics Median PS Value Chart

Panbela Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Median PS Value

Get a 7-Day Free Trial

0.00

Panbela Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Median PS Value	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PBLA vs VINC, OMGAQ, ENDV: Median PS Value Comparison

For the Biotechnology subindustry, Panbela Therapeutics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panbela Therapeutics Price-to-Median-PS-Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panbela Therapeutics's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Panbela Therapeutics's Price-to-Median-PS-Value falls into.

Save Embed

Panbela Therapeutics Median PS Value Calculation

Panbela Therapeutics's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0	*
	=	0.00

10-Year Median PS Ratio is .
Panbela Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.

Frequently Asked Questions Learn more about Median PS Value →

What does a Median PS Value of $0.00 mean?

Panbela Therapeutics (PBLA) has a Median PS Value of $0.00 as of Jul. 01, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Panbela Therapeutics and its competitors.

Is Panbela Therapeutics' Median PS Value too high?

Panbela Therapeutics' current Median PS Value is $0.00.

How does Panbela Therapeutics' Median PS Value compare to VINC and OMGAQ?

Panbela Therapeutics' Median PS Value of $0.00 can be compared against companies in the Biotechnology industry. The industry median Median PS Value is 0.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Median PS Value for a Biotechnology company?

The median Median PS Value among Biotechnology companies is 0.63, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Median PS Value mean?

A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Panbela Therapeutics and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panbela Therapeutics's current Median PS Value is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Panbela Therapeutics stock overvalued right now?

Panbela Therapeutics (PBLA) has a current Median PS Value of $0.00. The current Median PS Value is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Median PS Value calculated?

Median PS Value is calculated from a company's financial statements. For Panbela Therapeutics (PBLA), the current Median PS Value is $0.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panbela Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies VINC OMGAQ ENDV CYTOF ORGS RGBP GBLX VRPX CNBX KRBPQ VRTX ASX:CSL REGN ALNY XKRX:207940 XBRU:ARGX XBRU:UCB ONC INSM XKRX:068270

Address 712 Vista Boulevard, Suite 305, Waconia, MN, USA, 55387

Website https://www.panbela.com

Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X), which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity.